tiprankstipranks
ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Japanese Market
4528
ONO Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4528 full AI Analyst Report?

ONO Pharmaceutical Co (4528) Financial Statements

1 Followers

ONO Pharmaceutical Co Financial Overview

ONO Pharmaceutical Co's market cap is currently ¥1.14T. The company's EPS TTM is ¥148.49; its P/E ratio is 16.91; and it has a dividend yield of 3.63%. ONO Pharmaceutical Co is scheduled to report earnings on May 8, 2026, and the estimated EPS forecast is ¥35.37. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 26Mar 25Mar 24Mar 23
Income Statement
Total Revenue¥ 486.87B¥ 515.78B¥ 502.67B¥ 447.19B¥ 361.36B
Gross Profit¥ 335.47B¥ 374.07B¥ 372.67B¥ 334.28B¥ 264.91B
Operating Income¥ 63.38B¥ 103.33B¥ 163.56B¥ 152.29B¥ 114.91B
EBITDA¥ 90.28B¥ 141.09B¥ 181.70B¥ 169.75B¥ 132.63B
Net Income¥ 50.05B¥ 69.77B¥ 127.98B¥ 112.72B¥ 80.52B
Balance Sheet
Cash & Short-Term Investments¥ 210.38B¥ 237.11B¥ 204.59B¥ 164.29B¥ 116.97B
Total Assets¥ 1.06T¥ 1.11T¥ 913.67B¥ 882.44B¥ 739.20B
Total Debt¥ 146.68B¥ 120.94B¥ 8.86B¥ 9.17B¥ 8.80B
Net Debt¥ -57.89B¥ -116.11B¥ -157.28B¥ -86.97B¥ -60.31B
Total Liabilities¥ 275.84B¥ 249.87B¥ 115.06B¥ 134.62B¥ 77.53B
Stockholders' Equity¥ 782.45B¥ 850.73B¥ 792.96B¥ 741.87B¥ 655.91B
Cash Flow
Free Cash Flow¥ 77.03B¥ 130.80B¥ 106.64B¥ 154.27B¥ 56.33B
Operating Cash Flow¥ 82.46B¥ 136.82B¥ 110.66B¥ 159.61B¥ 61.83B
Investing Cash Flow¥ -136.78B¥ -39.86B¥ 48.08B¥ -100.26B¥ 6.04B
Financing Cash Flow¥ 94.30B¥ -65.49B¥ -89.85B¥ -32.48B¥ -60.24B
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History

Income Statement >

ONO Pharmaceutical Co Debt to Assets

Balance Sheet >

ONO Pharmaceutical Co Cash Flow

Cash Flow >

ONO Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >